Claims
- 1. A bleaching composition comprising:A) a catalytically effective amount of a transition-metal bleach catalyst which is a complex of a transition-metal and a cross-bridged macropolycyclic ligand; and B) the balance carriers and other adjunct ingredients; provided said composition is substantially free of any organic or inorganic peroxygen compounds.
- 2. A composition according to claim 1 wherein said transition-metal bleach catalyst comprises:i) a transition metal selected from the group consisting of Mn(II), Mn(III), Mn(IV), Mn(V), Fe(II), Fe(III), Fe(IV), Co(I), Co(II), Co(III), Ni(I), Ni(II), Ni(III), Cu(I), Cu(II), Cu(III), Cr(II), Cr(III), Cr(IV), Cr(V), Cr(VI), V(III), V(IV), V(V), Mo(IV), Mo(V), Mo(VI), W(IV), W(V), W(VI), Pd(II), Ru(II), Ru(III), Ru(IV), and mixtures thereof; ii) a cross-bridged macropolycyclic ligand being coordinated by four or five donor atoms to the same transition metal, said ligand comprising: a) an organic macrocycle ring containing four or more donor atoms separated from each other by covalent linkages of 2 or 3 non-donor atoms, two to five of these donor atoms being coordinated to the same transition metal atom in the complex; b) a cross-bridged chain which covalently connects at least 2 non-adjacent donor atoms of the organic macrocycle ring, said covalently connected non-adjacent donor atoms being bridgehead donor atoms which are coordinated to the same transition metal in the complex, and wherein said cross-bridged chain comprises from 2 to about 10 atoms; and III) optionally, one or more non-macropolycyclic ligands.
- 3. A composition according to claim 2 wherein said organic macrocycle ring comprises at least four donor atoms which are N, said donor atoms separated from each other by covalent linkages of from 2 to 4 non-donor atoms, said donor atoms coordinated to the same transition metal atom.
- 4. A composition according to claim 3 wherein said cross-bridged chain comprises 2, 3 or 4 non-donor atoms.
- 5. A composition according to claim 2 wherein said donor atoms in the organic macrocycle ring of the cross-bridged macropolycyclic ligand are selected from the group consisting of nitrogen, oxygen, sulfur, phosphorous, and mixtures thereof.
- 6. A composition according to claim 2 comprising a transition-metal bleach catalyst wherein at least four of the donor atoms in the cross-bridged macropolycyclic ligand, form an apical bond angle with the same transition metal of 180±50° and at least one equatorial bond angle of 90±20°.
- 7. A composition according to claim 2 comprising a transition-metal bleach catalyst wherein two of the donor atoms in the cross-bridged macropolycyclic ligand occupy mutually trans positions of the coordination geometry, and at least two of the donor atoms in the cross-bridged macropolycyclic ligand occupy cis-equatorial positions of the coordination geometry.
- 8. A composition according to claim 1 which comprises at least about 1 ppb of a transition-metal bleach catalyst.
- 9. A composition according to claim 1 wherein said transition-metal bleach catalyst is 5,12-dimethyl-1,5,8,12-tetraaza-bicyclo[6.6.2]hexadecane manganese(II) chloride.
- 10. A composition according to claim 1 wherein said transition-metal bleach catalyst is 5,12-diethyl-1,5,8,12-tetraaza-bicyclo[6.6.2]hexadecane manganese(II) chloride.
- 11. A liquid laundry, laundry pre-soak, or pre-treatment composition comprising:a) a catalytically effective amount of a transition-metal bleach catalyst which is a complex of a transition-metal and a cross-bridged macropolycyclic ligand; and b) the balance one or more liquid carriers; provided said composition is substantially free of any organic or inorganic peroxygen compounds.
- 12. A composition according to claim 11 wherein said catalyst comprises:i) a transition metal is selected from the group consisting of Mn(II), Mn(III), Mn(IV), Mn(V), Fe(II), Fe(III), Fe(IV), Co(I), Co(II), Co(III), Ni(I), Ni(II), Ni(III), Cu(I), Cu(II), Cu(III) Cr(II), Cr(III), Cr(IV), Cr(V), Cr(VI), V(III), V(IV), V(V), Mo(IV), Mo(V), Mo(VI), W(IV), W(V), W(VI), Pd(II), Ru(II), Ru(III), and Ru(IV), and; ii) a cross-bridged macropolycyclic ligand, said ligand is selected from the group consisting of: a) a cross-bridged macropolycyclic ligand of formula (I) having denticity of 4 or 5:b) a cross-bridged macropolycyclic ligand of formula (II) having denticity of 5 or 6: c) the cross-bridged macropolycyclic ligand of formula (III) having denticity of 6 or 7:wherein each E unit represents the moiety having the formula:(CRn)a—X—(CRn)a′wherein X is selected from the group consisting of oxygen, sulfur, —NR—, phosphorous, or X represents a covalent bond wherein E has the formula:(CRn)a—(CRn)a′for each E units the sum of a+a′ is independently selected from 1 to 5; each G unit is a moiety (CRn)b; each R unit is independently selected from H, alkyl, alkenyl, alkynyl, aryl, alkylaryl, and heteroaryl, or two or more R units are covalently bonded to form an aromatic, heteroaromatic, cycloalkyl, or heterocycloalkyl ring; each D unit is a donor atom independently selected from the group consisting of nitrogen, oxygen, sulfur, and phosphorous and at least two atoms which comprise D units are bridgehead donor atoms coordinated to the transition metal; B units are a carbon atom, a D unit, or a cycloalkyl or heterocyclic ring; each n is an integer independently selected from 1 and 2, completing the valence of the carbon atoms to which the R units are covalently bonded; each n′ is an integer independently selected from 0 and 1, completing the valence of the D donor atoms to which the R moieties are covalently bonded; each n″ is an integer independently selected from 0, 1, and 2 completing the valence of the B atoms to which the R moieties are covalently bonded; each a and a′ is an integer independently selected from 0 to 5, wherein the sum of all a+a′ values in the ligand of formula (I) is within the range of from about 8 to about 12; the sum of all a+a′ values in the ligand of formula (II) is within the range of from about 10 to about 15; and the sum of all a+a ′ values in the ligand of formula (III) is within the range of from about 12 to about 18; each b is an integer independently selected from 0 to 9, or in any of the above formulas, one or more of the (CRn)b moieties covalently bonded from any D to the B atom is absent as long as at least two (CRn)b covalently bond two of the D donor atoms to the B atom in the formula, and the sum of all b indices is within the range of from about 2 to about 5; andiii) optionally, one or more non-macropolycyclic ligands.
- 13. A composition according to claim 11 wherein said catalyst comprises a non-macropolycyclic ligand selected form the group consisting of H2O, ROH, NR3, RCN, OH−, OOH−, RS−, RO−, RCOO−, OCN−, SCN−, N3−, CN−, F−, Cl−, Br−, I−, O2−, NO3−, NO2−, SO42−, SO32−, PO43−, organic phosphates, organic phosphonates, organic sulfates, organic sulfonates, and aromatic N donors; wherein R is H, an alkyl moiety which is optionally substituted, or an aryl moiety which is optionally substituted.
- 14. A granular laundry, laundry pre-soak, or pre-treatment composition comprising:a) a catalytically effective amount of a transition-metal bleach catalyst which is a complex of a transition-metal and a cross-bridged macropolycyclic ligand; and b) the balance carriers fillers, and other adjunct ingredients: provided said composition is substantially free of any organic or inorganic peroxygen compounds.
- 15. A method for bleaching soils and stains on fabrics, said method comprising the step of contacting fabric in need of cleaning with an aqueous or non-aqueous solution containing a composition comprising:a) a catalytically effective amount of a transition-metal bleach catalyst which is a complex of a transition-metal and a cross-bridged macropolycyclic ligand; and b) the balance carriers fillers, and other adjunct ingredients; provided the concentration of said transition metal bleach catalyst in the solution is at least about 0.01 ppb and said composition is substantially free of any organic or inorganic peroxygen compounds.
- 16. A method according to claim 15 wherein said composition comprises an effective amount of 5,12dimethyl-1,5,8,12-tetraazabicyclo[6.6.2] hexadecane manganese (II) chloride.
- 17. A method according to claim 15 wherein said composition comprises an effective amount of 5,12diethyl-1,5,8,12-tetraazabicyclo[6.6.2] hexadecane manganese (II) chloride.
- 18. A method according to claim 15 wherein said solution contains less than 0.001% of an organic or inorganic peroxygen compound.
- 19. A method according to claim 18 wherein said composition comprises an effective amount of 5,12-dimethyl-1,5,8,12-tetraazabicyclo[6.6.2] hexadecane manganese (II) chloride.
- 20. A method according to claim 18 wherein said composition comprises an effective amount of 5,12-diethyl-1,5,8,12-tetraazabicyclo[6.6.2] hexadecane manganese (II) chloride.
- 21. A composition according to claim 2 wherein said transition metal bleach catalyst's transition metal is selected from the group consisting of Mn(II), Mn(III), Mn(IV), Fe(II), Fe(III), Fe(IV), Cr(II), Cr(III), Cr(IV), Cr(V), Cr(VI) and mixtures thereof.
- 22. A composition according to claim 2 wherein at least 3 of said transition metal bleach catalyst's organic macrocycle's four or more donor atoms are N.
- 23. A composition according to claim 2 wherein said transition metal bleach catalyst's optional, one or more non-macropolycyclic ligands are selected from the group consisting of H2O, ROH, NR3, RCN, OH−, OOH−, RS−, RO−, RCOO−, OCN−, SCN−, N3−, CN−, F−, Cl−, Br−, I−, O2−, NO3−, NO2−, SO42−, SO32−, PO43−, organic phosphates, organic phosphonates, organic sulfates, organic sulfonates, and aromatic N donors; wherein R is H, a substituted alkyl, or a substituted aryl.
- 24. A composition according to claim 23 wherein said aromatic N donors are selected from the group consisting of pyridines, pyrazines, pyrazoles, imidazoles, benzimidazoles, pyrimidines, triazoles and thiazoles.
- 25. A composition according to claim 13 wherein said aromatic N donors are selected from the group consisting of pyridines, pyrazines, pyrazoles, imidazoles, benzimidazoles, pyrimidines, triazoles and thiazoles.
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a continuation under 35 USC §120 to U.S. application Ser. No. 09/831,607, filed May 10, 2001, now abandoned, which is an entry into the U.S. National Stage under 35 U.S.C. §371 of PCT International Application Serial No. PCT/US99/26543, filed Nov. 9, 1999, which claims priority under PCT Article 8 and 35 U.S.C. §119(e) to U.S. Provisional Application Ser. No. 60/108,292 filed Nov. 13, 1998, (now abandoned.
US Referenced Citations (8)
Number |
Name |
Date |
Kind |
4888032 |
Busch |
Dec 1989 |
A |
5244594 |
Favre et al. |
Sep 1993 |
A |
6218351 |
Busch et al. |
Apr 2001 |
B1 |
6225464 |
Hiler, II et al. |
May 2001 |
B1 |
6306812 |
Perkins et al. |
Oct 2001 |
B1 |
6387862 |
Busch et al. |
May 2002 |
B2 |
6399557 |
Perkins et al. |
Jun 2002 |
B2 |
6444808 |
Hiler, II et al. |
Sep 2002 |
B2 |
Foreign Referenced Citations (6)
Number |
Date |
Country |
0 549 272 |
Jun 1993 |
EP |
0 553 607 |
Aug 1998 |
EP |
WO9839098 |
Sep 1998 |
WO |
WO 9839335 |
Sep 1998 |
WO |
WO 9839406 |
Sep 1998 |
WO |
WO9839406 |
Sep 1998 |
WO |
Non-Patent Literature Citations (5)
Entry |
U.S. patent application Ser. No. 10/228,854, Busch et al., filed Aug. 27, 2002. |
U.S. patent application Ser. No. 10/228,853, Busch et al., filed Aug. 27, 2002. |
U.S. patent application Ser. No. 10/093,115, Perkins et al., filed Mar. 7, 2002. |
U.S. patent application Ser. No. 10/142,085, Hiler et al., filed May 9, 2002. |
U.S. patent application Ser. No. 10/142,070, LaBeque, filed May 9, 2002. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/108292 |
Nov 1998 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09/831607 |
|
US |
Child |
10/142041 |
|
US |